Quanterix (QTRX) Shares Outstanding (Diluted Average) (2019 - 2026)
Quanterix posted quarterly Shares Outstanding (Diluted Average) of $47.0 million for Q1 2026, up 21.34% year-on-year from $38.7 million in Q1 2025, and up 10.18% on a QoQ basis from $42.6 million in Q4 2025.
Quanterix (QTRX) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $47.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 21.34% year-over-year to $47.0 million; the trailing twelve-month figure through Mar 2026 stood at $47.0 million (up 21.34% YoY), and the FY2025 full-year result was $42.6 million, up 11.13% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $47.0 million, up from $42.6 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $47.0 million in Q1 2026 and bottomed at $36.9 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $38.1 million (2024), against an average of $38.8 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) grew 1.29%; it then climbed 21.34% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $37.0 million in 2022, then grew by 1.63% to $37.6 million in 2023, then gained by 2.06% to $38.4 million in 2024, then advanced by 11.13% to $42.6 million in 2025, then rose by 10.18% to $47.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $47.0 million (Q1 2026), $42.6 million (Q4 2025), and $41.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 46.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.98 Mn |
| Dec 31, 2025 | 42.64 Mn |
| Sep 30, 2025 | 41.24 Mn |
| Jun 30, 2025 | 38.80 Mn |
| Mar 31, 2025 | 38.72 Mn |
| Dec 31, 2024 | 38.37 Mn |
| Sep 30, 2024 | 38.45 Mn |
| Jun 30, 2024 | 38.23 Mn |
| Mar 31, 2024 | 38.13 Mn |
| Dec 31, 2023 | 37.59 Mn |
| Sep 30, 2023 | 37.66 Mn |
| Jun 30, 2023 | 37.49 Mn |
| Mar 31, 2023 | 37.33 Mn |
| Dec 31, 2022 | 36.99 Mn |
| Sep 30, 2022 | 37.01 Mn |
| Jun 30, 2022 | 36.89 Mn |
| Mar 31, 2022 | 36.85 Mn |
| Dec 31, 2021 | 36.00 Mn |
| Sep 30, 2021 | 36.52 Mn |
| Jun 30, 2021 | 36.35 Mn |
| Mar 31, 2021 | 34.43 Mn |
| Dec 31, 2020 | 29.59 Mn |
| Dec 31, 2019 | 25.09 Mn |